Modulatory factors responsible for neoangiogenesis in young patients with long-standing diabetes mellitus type 1

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 3, Issue 2, 2009, Pages 144-149

  Zorena, Katarzyna ^a   Myśliwska, Jolanta ^a   Myśliwiec, Małgorzata ^a   Balcerska, Anna ^a   Lipowski, Paweł ^a   Raczyńska Wońniak, Dorota ^a   Raczyńska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Angiogenin; Children and adolescents; Retinopathy; Type 1 diabetes mellitus; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; INSULIN; VASCULOTROPIN;

ADOLESCENT; ANGIOGENESIS; BLOOD SAMPLING; CHILD; CHILD HEALTH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 70349245185     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221409788452381     Document Type: Review

References (32)

1. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Growth factor alterations in advanced diabetic retinopathy: A possible role of blood retina barrier breakdown. Diabetes 1997; 46(Suppl 2): S26-30.
2. Soro-Paavonen A, Forbes JM. Novel therapeutics for diabetic micro- and macrovascular complications. Curr Med Chem 2006; 13(15): 1777-1788.
3. Schram MT, Chaturvedi N, Schalkwijk C, et al. EURODIAB prospective complications study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2003; 26: 2165.
4. Kolberg CE, Abrahamsson M, Arnqvist HJ, Finnstrom K, Ludvigsson J. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with 1 diabetes. Diabet Med 2002; 19: 924-931.
5. Myśliwiec M, Zorena K, Balcerska A, Myśliwska J, Lipowski P, Raczyńska K. The activity of N-acetyl-beta-D- glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Clin Biochem 2006; 39: 851-856.
6. Zorena K, Myśliwska J, Myśliwiec M, et al. Serum TNF-alpha level predicts nonprolifetative diabetic retinopathy in children. Mediators Inflamm 2007; 2007: ID92196.
7. Zorena K, Myśliwska J, Myacsliwiec M, et al. Inflammatory and angiogenic facrors in children with diabetic retinopathy. Fam Med Prim Care Rev 2007; 9(4): 1007-1010.
8. Myśliwiec M, Balcerska A, Zorena K, Myśliwska J, Lipowski P, Raczyńska K. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Res Clin Pract 2008; 79: 141-146.
9. Kvanta A. Ocular angiogenesis: The role of growth factors. Acta Ophthalmol Scand 2006; 84: 282-288.
10. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006; 2: 71-98.
11. Näslund I, Norrby K. NO and de novo mammalian angiogenesis: Further evidence that NO inhibits bFGF-induced angiogenesis while not influencing VEGF165-induced angiogenesis. APMIS 2000; 108: 29-37.
12. Fam NP, Verma S, Kutryk M, et al. Clinical guide to angiogenesis. Circulation 2003; 108: 2613-2618.
13. Quijano, R. C., Tu, H.: US20087432241 (2008).
14. Li, M., Cheng, L., Liu, H. W.: US2008124388A1 (2008).
15. Tello-Montoliu A, Patel JV, Lip GY. Angiogenin: A review of the pathophysiology and potential clinical applications. J Thromb Haemost 2006; 4: 1864-1874.
16. American Diabetes Association. Fallow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
17. Early Treatment Diabetic Retinopathy Study Rerearch Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 1991; 98(Suppl 5): 807-822.
18. Lash GE, Schiessl B, Kirkley M, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 2006; 80: 572-580.
19. Kim SH, Choi YM, Chae HD, Kim CH, Kang BM. Decreased expression of angiogenin in the eutopic endometrium from women with advanced stage endometriosis. J Korean Med Sci 2008; 23: 802-807.
20. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003; 47: 149-161.
21. Zorena K, Myśliwska J, Myśliwiec M, Balcerska A, Lipowski P, Raczyńska K. Interleukin 12 and Tumor Necrosis Factor-α equilibrium is prerequisite for clinical course free from late complications in type 1 diabetes mellitus children. Scand J Immunol 2008; 67: 204-208.
22. Sochett E, Daneman D. Early diabetes-related complacations in children and adolescents with type 1 diabetes. Endocrinol Metab Clin North Am 1999; 28: 865-882.
23. Picchi A, Gao X, Belmadani S, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006: 99; 69-77.
24. Zorena K, Myśliwska J, Myśliwiec M, Balcerska A, Lipowski P, Raczyńska K. Relationship between serum levels of tumor necrosis factor-alpha and interleukin-6 in diabetes mellitus type 1 children. Cent Eur J Immunol 2007; 32 (3): 124-128.
25. Malamitsi-Puchner A, Sarandakou A, Dafogianni C, Tziotis J, Bartsocas CS. Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Res 1998; 43: 798-800.
26. Chiarelli F, Pomilo M, Mohn A, et al. Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 2002; 32: 110-114.
27. Donaghue KC, Fairchild JM, Craig ME, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 2003; 26(4): 1224-229.
28. Chiarelli F, Spagnoli A, Bascani F, et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: Relation to glycaemic control and microvascular complications. Diabet Med 2000; 17: 650-656.
29. Santilli F, Spagnoli A, Mohn A, et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 2001; 8: 3871-3876.
30. Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 2001; 132: 551-556.
31. Naskar R, Dreyer E. New Horisons in neuroprotection. Surv Ophthalmol 2001; 45: (Suppl 3): S250-255.
32. Olovnikov, A.M., Darashkevitch, O.N., Goufman, E.I.: WO2008006187A2 (2008).